Literature DB >> 15557659

Oral vaccination with recombinant Yersinia enterocolitica expressing hybrid type III proteins protects gerbils from amebic liver abscess.

Hannelore Lotter1, Holger Rüssmann, Jürgen Heesemann, Egbert Tannich.   

Abstract

Protection against invasive amebiasis was achieved in the gerbil model for amebic liver abscess by oral immunization with live attenuated Yersinia enterocolitica expressing the Entamoeba histolytica galactose-inhibitable lectin that has been fused to the Yersinia outer protein E (YopE). Protection was dependent on the presence of the YopE translocation domain but was independent from the antibody response to the ameba lectin.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15557659      PMCID： PMC529123          DOI： 10.1128/IAI.72.12.7318-7321.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  24 in total

Review 1.  Type III secretion machines: bacterial devices for protein delivery into host cells.

Authors:  J E Galán; A Collmer
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

2.  A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba.

Authors:  L S Diamond; D R Harlow; C C Cunnick
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

Review 3.  Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality.

Authors:  J A Walsh
Journal:  Rev Infect Dis       Date:  1986 Mar-Apr

4.  Primary structure of the 170-kDa surface lectin of pathogenic Entamoeba histolytica.

Authors:  E Tannich; F Ebert; R D Horstmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

5.  Protection of gerbils from amebic liver abscess by vaccination with a 25-mer peptide derived from the cysteine-rich region of Entamoeba histolytica galactose-specific adherence lectin.

Authors:  H Lotter; F Khajawa; S L Stanley; E Tannich
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

6.  Innate immunity to amebic liver abscess is dependent on gamma interferon and nitric oxide in a murine model of disease.

Authors:  K B Seydel; S J Smith; S L Stanley
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

7.  Cytokine activation of murine macrophages for in vitro killing of Entamoeba histolytica trophozoites.

Authors:  M Denis; K Chadee
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

8.  The Mongolian gerbil (Meriones unguiculatus) as an experimental host for Entamoeba histolytica.

Authors:  K Chadee; E Meerovitch
Journal:  Am J Trop Med Hyg       Date:  1984-01       Impact factor: 2.345

9.  Attenuated Yersinia pseudotuberculosis carrier vaccine for simultaneous antigen-specific CD4 and CD8 T-cell induction.

Authors:  Holger Rüssmann; Ulrike Gerdemann; Emeka I Igwe; Klaus Panthel; Jürgen Heesemann; Sara Garbom; Hans Wolf-Watz; Gernot Geginat
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  In vivo activation of macrophages by IFN-gamma to kill Entamoeba histolytica trophozoites in vitro.

Authors:  E Ghadirian; M Denis
Journal:  Parasite Immunol       Date:  1992-07       Impact factor: 2.280
View more
  11 in total

1.  CpG-oligodeoxynucleotide is a potent adjuvant with an Entamoeba histolytica Gal-inhibitable lectin vaccine against amoebic liver abscess in gerbils.

Authors:  Catherine P A Ivory; Kathy Keller; Kris Chadee
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 2.  The future for vaccine development against Entamoeba histolytica.

Authors:  Jeanie Quach; Joëlle St-Pierre; Kris Chadee
Journal:  Hum Vaccin Immunother       Date:  2014-02-06       Impact factor: 3.452

3.  LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.

Authors:  Wei Sun; Shilpa Sanapala; Jeremy C Henderson; Shandiin Sam; Joseph Olinzock; M Stephen Trent; Roy Curtiss
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

4.  Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen.

Authors:  R Aloni-Grinstein; O Gat; Z Altboum; B Velan; S Cohen; A Shafferman
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

Review 5.  Amebic colitis: new insights into pathogenesis and treatment.

Authors:  Tracy E Bercu; William A Petri; Jr W Behm
Journal:  Curr Gastroenterol Rep       Date:  2007-10

6.  Adherence-inhibitory intestinal immunoglobulin a antibody response in baboons elicited by use of a synthetic intranasal lectin-based amebiasis subunit vaccine.

Authors:  Mohamed D Abd Alla; Gary L White; Tyson B Rogers; Max E Cary; David W Carey; Jonathan I Ravdin
Journal:  Infect Immun       Date:  2007-05-25       Impact factor: 3.441

7.  Mucosal delivery of ACNPV baculovirus driving expression of the Gal-lectin LC3 fragment confers protection against amoebic liver abscess in hamster.

Authors:  D M Meneses-Ruiz; J P Laclette; H Aguilar-Díaz; J Hernández-Ruiz; A Luz-Madrigal; A Sampieri; L Vaca; J C Carrero
Journal:  Int J Biol Sci       Date:  2011-11-01       Impact factor: 6.580

8.  Progress in the research on diagnosis and vaccines in amebiasis.

Authors:  Subhash Chandra Parija
Journal:  Trop Parasitol       Date:  2011-01

9.  Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice.

Authors:  Balraj Premanand; Mookkan Prabakaran; Tanja K Kiener; Jimmy Kwang
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

Review 10.  Oral Vaccination of Fish - Antigen Preparations, Uptake, and Immune Induction.

Authors:  Stephen Mutoloki; Hetron Mweemba Munang'andu; Øystein Evensen
Journal:  Front Immunol       Date:  2015-10-19       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.